Akèy › Myelofibroz › Alabama › Birmingham
Etid klinik pou Myelofibroz nan Birmingham, AL
7 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Ap rekriteFaz 1/2
- University of Alabama, Birmingham
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- University of Alabama At Birmingham, Birmingham
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
Ap rekriteFaz 1
- University of Alabama at Birmingham, Birmingham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- University of Alabama Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Birmingham
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Ap rekriteFaz 3
- UAB Hospital, Birmingham
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
Ap rekriteFaz 1/2
- University of Alabama at Birmingham, Birmingham
Etid Myelofibroz nan lòt vil
- Houston, TX19 etid
- New York City, NY18 etid
- Boston, MA12 etid
- Durham, NC12 etid
- Columbus, OH11 etid
- Seattle, WA11 etid
- Miami, FL10 etid
- Salt Lake City, UT10 etid
- Atlanta, GA9 etid
- Tampa, FL9 etid
- Nashville, TN9 etid
- Cleveland, OH9 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)30 etid
- Kansè nan tete24 etid
- Obèsite23 etid
- Kansè ovè23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Sipwa16 etid
- Kansè Endomèt16 etid
- Dyabèt Tip 216 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.